Atlas Trials

Immunogenicity Study of an Anti-pneumococcal Vaccination Strategy in Patients With Sickle Cells Disease

Clinical trial NCT02274415 · COMPLETED

Trial details

NCT number
NCT02274415
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Invasive Pneumococcal InfectionsSickle Cells Disease
Start date
2013-09-16
Primary completion
2017-09-18
Enrollment
116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.